Olshan's Client Footstar Acquires CPEX Pharma

YAHOO! Finance reported on Olshan’s client, Footstar, Inc's deal to acquire 80.5% of CPEX Pharmaceuticals, Inc., a publicly-traded specialty pharmaceutical company, in a transaction valued at approximately $76.6 million.  The transaction is being financed through equity,a $64 million secured term loan and $13 million of bridge financing.

The Olshan team that worked on this transaction included: Corporate: Kenneth A. Schlesinger, Jason W. Soncini and Camielle N. Green; Tax: Nina Krauthamer.